InsidersTradesSigma
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Mehra Anand, Director. Insider active across 1 company, notably Aclaris Therapeutics, Inc.. Aggregated, 5 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €1.4m. Activity tracked since 19 November 2024. The latest transaction was filed on 19 November 2024 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
5 of 5 declarations
Anand Mehra is a Board Member at Aclaris Therapeutics, Inc. He oversees the company's operations and participates in strategic decision-making. Anand is committed to promoting strong governance practices and ensuring regulatory compliance.